MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 37 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,000 | -55.6% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $18,000 | -84.2% | 2,000 | -89.2% | 0.00% | – |
| Q2 2022 | $114,000 | -32.9% | 18,500 | -30.2% | 0.00% | – |
| Q1 2022 | $170,000 | 0.0% | 26,502 | +1.9% | 0.00% | – |
| Q4 2021 | $170,000 | +14.1% | 26,003 | -0.7% | 0.00% | – |
| Q3 2021 | $149,000 | +14800.0% | 26,195 | +13063.3% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 199 | -34.3% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 303 | +94.2% | 0.00% | – |
| Q4 2020 | $1,000 | – | 156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,425,737 | $22,293,000 | 3.44% |
| Lion Point Capital, LP | 1,557,233 | $11,186,000 | 2.46% |
| ACUTA CAPITAL PARTNERS, LLC | 597,026 | $5,487,000 | 2.36% |
| Ikarian Capital, LLC | 855,616 | $7,863,000 | 1.57% |
| GREAT POINT PARTNERS LLC | 674,656 | $6,200,000 | 1.49% |
| Bleichroeder LP | 512,500 | $4,710,000 | 0.98% |
| RTW INVESTMENTS, LP | 4,315,102 | $39,656,000 | 0.91% |
| Novo Holdings A/S | 2,000,000 | $18,380,000 | 0.88% |
| Paradigm Biocapital Advisors LP | 634,211 | $5,828,000 | 0.78% |
| Ikarian Capital, LLC | 338,000 | $3,107,000 | 0.62% |